Pulmonary Embolism WArsaw REgistry

Launched by MEDICAL UNIVERSITY OF WARSAW · Apr 15, 2019

Keywords

ClinConnect Summary

The Pulmonary Embolism WArsaw REgistry, also known as the PE-aWARE study, is a research project that began in January 2008. It focuses on understanding acute pulmonary embolism (APE), a serious condition where a blood clot blocks blood flow to the lungs. The goal of this study is to gather detailed information about patients with APE, including their characteristics, treatments, and outcomes. By doing this, researchers aim to find ways to reduce the risk of death, bleeding complications, and future blood clots in these patients. The information collected will also help doctors create tools that can improve patient care.

To be eligible for the study, participants must have a confirmed diagnosis of pulmonary embolism and give their consent to join the research. This study welcomes patients of all genders and is currently recruiting individuals aged 65 and older. If you participate, you can expect to share your medical information and undergo regular monitoring to help researchers gain insights into this condition. Your involvement could contribute to better understanding and treatment of pulmonary embolism in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • objectively confirmed pulmonary embolism
• • Informed consent for the participation in the study, according to the requirements of the ethics committee
• Exclusion Criteria:
• • lack of consent